Inventor
CHAVA SATYANARAYANA
IN36 patents
⚠️ This page may combine multiple inventors who share the name “CHAVA SATYANARAYANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LAURUS LABS LTD
18 patentsUS9957234B2May 1, 2018
Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof
LAURUS LABS LTD2 citations68
US10428053B2Oct 1, 2019
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
LAURUS LABS LTD3 citations67
US11427570B2Aug 30, 2022
Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
LAURUS LABS LTD0 citations58
US11299477B2Apr 12, 2022
Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof
LAURUS LABS LTD0 citations58
US11414386B2Aug 16, 2022
Process for the preparation of ivacaftor and its intermediates
LAURUS LABS LTD0 citations57
US11040961B2Jun 22, 2021
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
LAURUS LABS LTD0 citations57
US10654872B1May 19, 2020
Polymorphs of dolutegravir and salts thereof
LAURUS LABS LTD0 citations48
US10647729B1May 12, 2020
Polymorphs of dolutegravir and salts thereof
LAURUS LABS LTD0 citations48
US10597404B2Mar 24, 2020
Polymorphs of dolutegravir and salts thereof
LAURUS LABS LTD0 citations48
US10836753B2Nov 17, 2020
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
LAURUS LABS LTD0 citations47
US10815202B2Oct 27, 2020
Process for the preparation of ivacaftor
LAURUS LABS LTD0 citations47
US10738038B2Aug 11, 2020
Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
LAURUS LABS LTD0 citations47
US10800809B2Oct 13, 2020
Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
LAURUS LABS LTD0 citations45
US10301321B2May 28, 2019
Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
LAURUS LABS LTD0 citations45
US10626091B2Apr 21, 2020
Process for the preparation of enzalutamide
LAURUS LABS LTD0 citations43
US11066368B2Jul 20, 2021
Process for the preparation and particle size reduction of pirfenidone
LAURUS LABS LTD0 citations42
US10131636B2Nov 20, 2018
Process for the preparation of Enzalutamide
LAURUS LABS LTD0 citations40
US10669264B2Jun 2, 2020
Process for the preparation of macitentan
LAURUS LABS LTD0 citations32
LAURUS LABS PRIVATE LTD
8 patentsUS9573902B2Feb 21, 2017
Process for the preparation of Ivacaftor and its intermediates
LAURUS LABS PRIVATE LTD3 citations69
US9388113B2Jul 12, 2016
Salts of sitagliptin, process from the preparation and pharmaceutical composition therefore
LAURUS LABS PRIVATE LTD0 citations48
US9181256B2Nov 10, 2015
Salts of sitagliptin, process for the preparation and pharmaceutical composition therefore
LAURUS LABS PRIVATE LTD0 citations48
US8367834B2Feb 5, 2013
Process for preparing Montelukast and salts thereof
LAURUS LABS PRIVATE LTD1 citations48
US10730859B2Aug 4, 2020
Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
LAURUS LABS PRIVATE LTD0 citations47
US10501419B2Dec 10, 2019
Processes for the preparation of ivacaftor
LAURUS LABS PRIVATE LTD0 citations46
US10364269B2Jul 30, 2019
Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
LAURUS LABS PRIVATE LTD0 citations45
US9856271B2Jan 2, 2018
Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
LAURUS LABS PRIVATE LTD0 citations45